Papillary renal cell carcinoma

Common Name(s)

Papillary renal cell carcinoma

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Papillary renal cell carcinoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Papillary renal cell carcinoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Papillary renal cell carcinoma" returned 107 free, full-text research articles on human participants. First 3 results:

Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease.
 

Author(s): Nina Wagener, Dominic Edelmann, Axel Benner, Richard Zigeuner, Hendrik Borgmann, Ingmar Wolff, Laura M Krabbe, Mireia Musquera, Paolo Dell'Oglio, Umberto Capitanio, Tobias Klatte, Luca Cindolo, Matthias May, Sabine D Brookman-May,

Journal:

 

Renal cell carcinoma (RCC) comprises a heterogenous group of tumors. Traditionally, papillary RCC (pRCC) is associated with a favorable outcome compared to clear cell RCC (ccRCC), while other series report equivalent or worse prognosis. In this paper we comparatively evaluate outcome ...

Last Updated: 21 Sep 2017

Go To URL
[Colon adenocarcinoma and synchronous type 1 papillary renal cell carcinoma: a unique association].
 

Author(s): Asma Sassi, Dhouha Bacha, Ghofrane Talbi, Sana Ben Slama, Rahma Boughriba, Zeineb Mzoughi, Saadia Bouraoui, Ahlem Lahmar

Journal:

 

The detection of primary tumors synchronous with colorectal cancer has been the subject of multiple publications. This association can occur sporadically or fall under the framework of well defined clinical syndromes such as Lynch syndrome. Synchronous association of colorectal cancer ...

Last Updated: 1 Aug 2017

Go To URL
Papillary renal cell carcinoma-derived chemerin, IL-8, and CXCL16 promote monocyte recruitment and differentiation into foam-cell macrophages.
 

Author(s): Krzysztof M Krawczyk, Helén Nilsson, Roni Allaoui, David Lindgren, Michael Arvidsson, Karin Leandersson, Martin E Johansson

Journal: Lab. Invest.. 2017 Nov;97(11):1296-1305.

 

Papillary renal cell carcinoma (pRCC) is the second most common type of renal cell carcinoma. The only curative treatment available for pRCC is radical surgery. If the disease becomes widespread, neither chemo- nor radiotherapy will have therapeutic effect, hence further research ...

Last Updated: 31 Jul 2017

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Papillary renal cell carcinoma" returned 8 free, full-text review articles on human participants. First 3 results:

Metachronous bladder metastases of a type 2 papillary renal cell carcinoma: a case report and review of the literature.
 

Author(s): D G V D Seneth Gajasinghe, Ishra Nazeer, Hansika P Maddumage, Chrysantha Perera, Anuruddha M Abeygunasekera

Journal:

 

Renal cell carcinoma developing metastases in the bladder is rare. Bladder metastasis due to a papillary type of renal cell carcinoma is rarer. Such metastases could be synchronous or metachronous.

Last Updated: 23 Aug 2016

Go To URL
Clear cell papillary renal cell carcinoma, renal angiomyoadenomatous tumor, and renal cell carcinoma with leiomyomatous stroma relationship of 3 types of renal tumors: a review.
 

Author(s): Ondrej Hes, Eva Maria Compérat, Nathalie Rioux-Leclercq

Journal: Ann Diagn Pathol. 2016 Apr;21():59-64.

 

Renal angiomyoadenomatous tumor has been described in 2000, followed by description of clear cell papillary renal cell carcinoma in 2006. Discussions about possible relationship of both tumors were published since their description. The main differential diagnostic feature was considered ...

Last Updated: 4 Apr 2016

Go To URL
Papillary renal cell carcinoma: A review of the current therapeutic landscape.
 

Author(s): Giulia Courthod, Marcello Tucci, Massimo Di Maio, Giorgio V Scagliotti

Journal: Crit. Rev. Oncol. Hematol.. 2015 Oct;96(1):100-12.

 

Renal cell carcinoma (RCC) is the most common cancer of the kidney and accounts for 2-3% of all adult malignancies. Clear cell carcinoma represents the most common histologic subtype, while papillary Renal Cell Carcinoma (pRCC) accounts for 10-20% of all renal cell cancers. While ...

Last Updated: 28 Sep 2015

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Axitinib in1st Line Treatment for Patients With Advanced or Metastatic Papillary Renal Cell Carcinoma
 

Status: Recruiting

Condition Summary: Papillary Renal Cell Carcinoma

 

Last Updated: 11 Sep 2017

Go to URL
Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma
 

Status: Recruiting

Condition Summary: Renal Cell Carcinoma; Hereditary Leiomyomatosis and Renal Cell Cancer; Papillary Renal Cell Carcinoma, Sporadic

 

Last Updated: 18 Oct 2017

Go to URL
A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer
 

Status: Recruiting

Condition Summary: Papillary Renal Cell Carcinoma

 

Last Updated: 18 Oct 2017

Go to URL